Effect of gastric acid suppression by use of vonoplaza
Not Applicable
- Conditions
- healthy person
- Registration Number
- JPRN-UMIN000025469
- Lead Sponsor
- ational Hospital Organization Hakodate Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Subjects with history of gastric ulcer or duodenum ulcer (2)Subjects with a serious complication of liver failure (3)Subjects with a serious complication of renal failure (4)Subjects with a serious complication of heart failure (5)Subjects treated with atazanavir sulfate (Reyataz) or rilpivirine hydrochloride (Edurant) (6)Subjects with Zollinger-Ellison syndrome (7)Subjects with history of surgery that affects gastric-acid secretion (8)Subjects with a history of allergy to the investigational product (9)Subjects with atrophic gastritis, gastric tumor, gastric ulcer or duodenum ulcer by endoscopic examination.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method